US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sable Offshore Corp.

26.13

-0.0400-0.15%

Post-market: 27.321.19+4.55%17:20 EDT

Volume:641.50K

Turnover:16.86M

Market Cap:2.34B

PE:-2.84

High:27.06

Open:26.20

Low:25.90

Close:26.17

Loading ...

Overview Company News Filings

Rapid7 Announces Global Capability Center in India

Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer

Bridgeline Digital announces completion of SOC 2 Type II attestation

Bridgeline Announces Completion of SOC 2 Type II Attestation

ACCESS Newswire

Kyndryl Foundation Expands Second-Year Funding to 11 Countries to Advance Cybersecurity and AI Skills Development

Scholar Rock Reports Full Year 2024 Financial Results and Highlights Business Progress

Allogene Therapeutics Expands Strategic Partnership with Foresight Diagnostics to Advance Joint Development Activities Outside the US Across Europe, UK, Canada, and Australia

MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care

Sable Offshore Challenges California Coastal Commission's Order Related to Repair Work

MT Newswires Live

Sable Offshore Claims Cease-and-Desist is Invalid, Pipeline Work Is Authorized

BRIEF-Sable Offshore Corp Files Complaint Against California Coastal Commission

Sable Offshore Corp - on Feb 16, California Coastal Commission (Ccc) Issued Notice to Sable Offshore for Anomaly Repair Work

THOMSON REUTERS

Sable Offshore Corp trading halted, news pending

U.S. RESEARCH ROUNDUP-Boeing, Philip Morris, Walmart

Sable Offshore Corp : Jefferies Raises Target Price to $38 From $28

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SOC/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SOC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SOC\",,,,,undefined,":{"symbol":"SOC","market":"US","secType":"STK","nameCN":"Sable Offshore Corp.","latestPrice":26.13,"timestamp":1743105600000,"preClose":26.17,"halted":0,"volume":641495,"hourTrading":{"tag":"盘后","latestPrice":27.32,"preClose":26.13,"latestTime":"17:20 EDT","volume":22896,"amount":598272.892128,"timestamp":1743110403263},"delay":0,"floatShares":57477544,"shares":89413358,"eps":-9.210924,"marketStatus":"Post-Market Trading","change":-0.04,"latestTime":"03-27 18:05:40 EDT","open":26.2,"high":27.06,"low":25.9008,"amount":16858535.429135002,"amplitude":0.044295,"askPrice":27.44,"askSize":10,"bidPrice":24.5,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-9.210924,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1743120000000},"marketStatusCode":4,"adr":0,"exchange":"NYSE","adjPreClose":26.17,"preHourTrading":{"tag":"盘前","latestPrice":26.75,"preClose":26.17,"latestTime":"09:28 EDT","volume":509,"amount":13629.109723000001,"timestamp":1743082102181},"postHourTrading":{"tag":"盘后","latestPrice":27.32,"preClose":26.13,"latestTime":"17:20 EDT","volume":22896,"amount":598272.892128,"timestamp":1743110403263},"volumeRatio":0.607895,"impliedVol":0.7837,"impliedVolPercentile":0.3418},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SOC\",,,,,undefined,":{"symbol":"SOC","floatShares":57477544,"roa":"-13.45%","roe":"-173.97%","lyrEps":-9.210924,"volumeRatio":0.607895,"shares":89413358,"dividePrice":0,"high":27.06,"amplitude":0.044295,"preClose":26.17,"low":25.9008,"week52Low":10.11,"pbRate":"6.08","week52High":32.33,"institutionHeld":0,"latestPrice":26.13,"eps":-9.210924,"divideRate":0,"volume":641495,"delay":0,"ttmEps":-9.210924,"open":26.2,"prevYearClose":22.9,"prevWeekClose":25.12,"prevMonthClose":28.37,"prevQuarterClose":22.9,"fiveDayClose":25.95,"twentyDayClose":27.77,"sixtyDayClose":23.85},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SOC\",pageSize:16,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2520529881","title":"Rapid7 Announces Global Capability Center in India","url":"https://stock-news.laohu8.com/highlight/detail?id=2520529881","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520529881?lang=en_us&edition=fundamental","pubTime":"2025-03-17 21:00","pubTimestamp":1742216400,"startTime":"0","endTime":"0","summary":"New Pune hub will house technology, security operations, customer support, and IT teams to drive AI innovation, regional growth, and cyber partnerships in region. BOSTON, March 17, 2025  -- Rapid7, Inc., Inc. , a leader in extended risk and threat detection, today announced plans for expansion in India, including the opening of a new Global Capability Center  in Pune to serve as an innovation hub and Security Operations Center . In addition, the company announced a series of in-region events to engage with government, education, and talent stakeholders on Rapid7’s commitment to enable customers to simplify security, take control of their attack surface, and confidently navigate a dynamic threat landscape.The GCC will open in April 2025 with a focus on expanding Rapid7’s ability to provide seamless, 24x7 security operations coverage to their growing global customers worldwide. Hiring for the new office will prioritize building a team that drives product and service innovation in cyber o","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/rapid7-announces-global-capability-center-130000042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SOC","RPD","GCC","BK4097","ASM","BK4213","BK4188","LU1878469433.USD"],"gpt_icon":0},{"id":"2520965587","title":"Scholar Rock Presents New Phase 3 SAPPHIRE Data at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2520965587","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520965587?lang=en_us&edition=fundamental","pubTime":"2025-03-17 07:00","pubTimestamp":1742166000,"startTime":"0","endTime":"0","summary":"Primary endpoint showed clinically meaningful improvement in patients with SMA receiving apitegromab as measured by gold standard Hammersmith Functional Motor Scale Expanded  versus placebo , with consistent outcomes across all major sub-groups including age, SMN-targeted background therapy, and age at initiation of SMN-targeted therapy. Pre-specified secondary endpoint showed that 30.4% of patients receiving apitegromab had ≥ 3-point improvement in HFMSE versus 12.5% of patients on placebo , despite all study patients receiving ongoing SMN-targeted background therapy. During this week’s 2025 MDA Conference, the SAPPHIRE trial presentations highlight new data including secondary endpoint analyses. In addition to achieving the SAPPHIRE trial’s primary endpoint as previously announced in October 2024, apitegromab demonstrated a clinically meaningful and consistent benefit in motor function across pre-specified patient subgroups . Efficacy was also consistent across patient outcome measur","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scholar-rock-presents-phase-3-230000179.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4218","BK4139","LU1169590202.USD","PD","BK4023","MDA","SOC","PK","LU1169589451.USD","BK4181","SRRK","BK4213"],"gpt_icon":0},{"id":"2518322658","title":"Natera Announces Enrollment of First Patients in the HEROES Clinical Trial in Metastatic HER2+ Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2518322658","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518322658?lang=en_us&edition=fundamental","pubTime":"2025-03-10 20:00","pubTimestamp":1741608000,"startTime":"0","endTime":"0","summary":"HEROES is Natera’s first clinical trial using Signatera to guide de-escalation of therapy in patients with metastatic HER2+ breast cancer. Approximately 170 patients are expected to enroll in up to 35 sites in France. Human epidermal growth factor receptor 2  is a type of protein found in cancer cells that can cause rapid cancer growth when higher than normal levels are present. Between 15%-20% of breast tumors are HER2+. Current standard-of-care  recommendations for maintenance treatment include the use of anti-HER2 therapies, which for many patients means remaining on the drug for life.\"We are excited to see the first patients enrolled in the HEROES clinical trial,\" said Angel Rodriguez, M.D., senior medical director of oncology at Natera. \"Safely discontinuing treatment has been a long-lasting dile","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/natera-announces-enrollment-first-patients-120000446.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065171311.SGD","BK4139","SOC","LU2264538146.SGD","CLIA","LU0963586101.USD","LU2065171402.SGD","LU2065170008.USD","BK4213","NTRA","LU2324357040.USD","LU1064131342.USD","LU0012050646.USD","LU0106261612.USD","LU1988902786.USD","LU2065731478.USD","LU0053671581.USD","LU2065169927.USD"],"gpt_icon":0},{"id":"2517168858","title":"Bridgeline Digital announces completion of SOC 2 Type II attestation","url":"https://stock-news.laohu8.com/highlight/detail?id=2517168858","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517168858?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:46","pubTimestamp":1741268768,"startTime":"0","endTime":"0","summary":"Bridgeline Digital (BLIN) completed another SOC 2 Type II audit, reaffirming its commitment to the highest standards of security, availability, and...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bridgeline-digital-announces-completion-of-soc-2-type-ii-attestation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bridgeline-digital-announces-completion-of-soc-2-type-ii-attestation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4512","BLIN","LU2360107325.USD","BK4588","LU2357305700.SGD","SOC","ON","LU1861219969.SGD","BK4023","IE00BZ199S13.USD","LU0724618433.USD","LU1720051108.HKD","LU1720051017.SGD","LU2298322129.HKD","LU1548497426.USD","LU1854103824.USD","LU1861215975.USD","LU1854104046.USD","LU0124384867.USD","BK4141","BK4585","LU1978683503.SGD","LU1861220033.SGD","LU1861214812.USD","BK4213","BK4605","IE00BD6J9T35.USD","LU0348723411.USD"],"gpt_icon":0},{"id":"2517157726","title":"Bridgeline Announces Completion of SOC 2 Type II Attestation","url":"https://stock-news.laohu8.com/highlight/detail?id=2517157726","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517157726?lang=en_us&edition=fundamental","pubTime":"2025-03-06 21:30","pubTimestamp":1741267800,"startTime":"0","endTime":"0","summary":"Independent Audit Verifies Bridgeline's Commitment to Internal Controls and Processes. WOBURN, MASSACHUSETTS / ACCESS Newswire / March 6, 2025 / Bridgeline Digital, Inc. , a leader in AI-driven marketing technology, has successfully completed another SOC 2 Type II audit, reaffirming its commitment to the highest standards of security, availability, and confidentiality.The SOC 2 Type II certification provides an independent, third-party validation that a service organization's information security practices meet industry standards stipulated by the American Institute of Certified Public Accountants . During the audit, a service organization's non-financial reporting controls as they relate to security, availability, processing integrity, confidentiality, and privacy of a system are tested. The SOC 2 report delivered verifies the suitability of the design and operating effectiveness of Bridgeline's controls to meet the standards for these criteria, ensuring customers can rely on secure a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bridgeline-announces-completion-soc-2-133000556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","BLIN","SOC","ON","BK4023"],"gpt_icon":0},{"id":"2516667625","title":"Kyndryl Foundation Expands Second-Year Funding to 11 Countries to Advance Cybersecurity and AI Skills Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2516667625","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516667625?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:00","pubTimestamp":1741093200,"startTime":"0","endTime":"0","summary":"The program serves new markets and introduces select multi-year grants to deepen community impact. NEW YORK, March 4, 2025 /PRNewswire/ -- Kyndryl Foundation, the philanthropic arm of Kyndryl, today announced that 12 nonprofit organizations from 11 countries have been awarded its second-year grants. The program is expected to touch the lives of more than 55,000 people over the next two years through cybersecurity and artificial intelligence  skills development, awareness and job placement initiatives.Building on the positive impact of its inaugural year, Kyndryl Foundation is extending its philanthropic support to serve nonprofits from five additional countries – Brazil, Canada, Costa Rica, Spain and the United Kingdom. Countries already served by Kyndryl Foundation include the Czech Republic, Hungary, India, Japan, Poland and the United States. The Foundation has also introduced select multi-year grants – up to two years at a time – to build deeper engagements with grantees and create","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/kyndryl-foundation-expands-second-funding-130000573.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/kyndryl-foundation-expands-second-funding-130000573.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4233","IE00B19Z4B17.USD","KD","BK4205","IE0031619046.USD","BK4213","IE00B7SZL793.SGD","UK","IE00B66KJ199.SGD","BK4134","BK4528","SOC"],"gpt_icon":0},{"id":"2514499805","title":"Scholar Rock Reports Full Year 2024 Financial Results and Highlights Business Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2514499805","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514499805?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657600,"startTime":"0","endTime":"0","summary":"- Submitted apitegromab U.S. Biologics License Application  for patients with spinal muscular atrophy in January 2025; U.S. launch anticipated in 4Q 2025. - Remain on track to submit European Union marketing authorisation application  in 1Q 2025. Submitted a biologics license application  to the U.S. Food and Drug Administration ; on track to submit a marketing authorisation application  to the European Medicines Agency  in 1Q 2025. BLA submission is based on the positive Phase 3 SAPPHIRE trial data that demonstrated a statistically significant and clinically meaningful improvement in motor function for patients receiving apitegro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/scholar-rock-reports-full-2024-120000657.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GB00BDT5M118.USD","BK4139","COO","CFO","PRGS","BK4213","BK4157","LU2211815571.USD","MAA","LU1992135472.HKD","BK4585","BMI","BK4198","LU2272731782.SGD","LU1992135399.USD","BK4215","LU2272731600.USD","SOC","BK4097","SRRK","LU2065732104.USD","BK4588"],"gpt_icon":0},{"id":"2514204170","title":"Allogene Therapeutics Expands Strategic Partnership with Foresight Diagnostics to Advance Joint Development Activities Outside the US Across Europe, UK, Canada, and Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2514204170","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514204170?lang=en_us&edition=fundamental","pubTime":"2025-02-26 05:10","pubTimestamp":1740517800,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Feb. 25, 2025  -- Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T  products for cancer and autoimmune disease, today announced an expanded strategic collaboration with Foresight Diagnostics, Inc. to include the development of Foresight’s minimal residual disease  assay as a companion diagnostic to identify patients with large B-cell lymphoma  for treatment with cemacabtagene ansegedleucel .About Cemacabtagene Ansegedleucel Cemacabtagene ansegedleucel, or cema-cel, is a next generation anti-CD19 AlloCAR T investigational product for the treatment of large B-cell lymphoma . In June 2022, the U.S. Food and Drug Administration granted Regenerative Medicine Advanced Therapy  designation to cema-cel in r/r LBCL. The ALPHA3 pivotal Phase 2 trial in first-line  consolidation for the treatment of LBCL launched in June 2024. Allogene has oncology rights to cema-cel in the US, EU and UK with options f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allogene-therapeutics-expands-strategic-partnership-211000027.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0082616367.USD","SG9999015945.SGD","LU0719512351.SGD","IE00B7SZLL34.SGD","LU1316542783.SGD","SG9999015986.USD","LU1814569148.SGD","BK4588","LU2264538146.SGD","SOC","SGXZ31699556.SGD","LU1861219969.SGD","LU0106261372.USD","SG9999014906.USD","ALLO","SG9999014898.SGD","IE0002270589.USD","SG9999018865.SGD","SG9999015978.USD","IE00BZ199S13.USD","IE00B19Z3581.USD","BK4022","SG9999014914.USD","GB00BDT5M118.USD","LENZ","SG9999017495.SGD","JYNT","BK4505","BK4551","LU1983260115.SGD","BK4185","BK4585","LU1988902786.USD","SG9999014880.SGD","LU0353189680.USD","LU0127658192.USD","IE00B19Z3B42.SGD","LU0006306889.USD","SG9999015952.SGD","BK4503","LU1861214812.USD","BK4139","BK4550","BK4213","LU0353189763.USD","SG9999018857.SGD","LU1064131342.USD","BK4536","BK4230","UBER"],"gpt_icon":0},{"id":"2514099937","title":"MediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2514099937","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514099937?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:00","pubTimestamp":1740488400,"startTime":"0","endTime":"0","summary":"Findings in Burns Journal confirm NexoBrid’s superiority over standard of care in pediatric patients with deep thermal burnsNexoBrid is approved for pediatric use in the U.S., E.U. and Japan YAVNE, Is","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/25/3031952/30505/en/MediWound-Announces-Phase-III-CIDS-Publication-on-NexoBrid-for-Pediatric-Burn-Care.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1854104046.USD","LU1720051017.SGD","BK4512","BK4144","BK4007","BK4141","NEXT","LU0724618433.USD","LU1861214812.USD","BK4134","BK4213","LU1548497426.USD","IE00BD6J9T35.USD","LU2360107325.USD","BK4605","LU1720051108.HKD","LU2298322129.HKD","MDWD","IE00BZ199S13.USD","LU1861220033.SGD","BK4585","LU1861219969.SGD","ON","III","LU1854103824.USD","LU1978683503.SGD","FT","LU2357305700.SGD","LU0348723411.USD","LU1861215975.USD","SOC","LU0124384867.USD","BK4588"],"gpt_icon":0},{"id":"2512480468","title":"Sable Offshore Challenges California Coastal Commission's Order Related to Repair Work","url":"https://stock-news.laohu8.com/highlight/detail?id=2512480468","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512480468?lang=en_us&edition=fundamental","pubTime":"2025-02-20 01:53","pubTimestamp":1739987610,"startTime":"0","endTime":"0","summary":"Sable Offshore  said Wednesday it filed a complaint challenging the California Coastal Commission's cease and desist order related to the company's anomaly repair activities along portions of Las Flores Pipelines.The company said the commission doesn't have the authority to prohibit work that existing permits authorize.Among other things, the company seeks a declaration that the commission's actions are unlawful and an injunction prohibiting the commission from taking further enforcement actions, according to the complaint filed on Tuesday in the Superior Court of the State of California for the County of Santa Barbara.The California Coastal Commission didn't immediately respond to a request for comment from MT Newswires.Price: 31.30, Change: -0.01, Percent Change: -0.03","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SOC.AU","SOC","BK7061","BK4213"],"gpt_icon":0},{"id":"2512487227","title":"Sable Offshore Claims Cease-and-Desist is Invalid, Pipeline Work Is Authorized","url":"https://stock-news.laohu8.com/highlight/detail?id=2512487227","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512487227?lang=en_us&edition=fundamental","pubTime":"2025-02-20 01:23","pubTimestamp":1739985780,"startTime":"0","endTime":"0","summary":"Sable Offshore said it strongly disagrees with many assertions made by Kate Huckelbridge, executive director of the California Coastal Commission, in a cease-and-desist order issued earlier this week regarding work being done to two of the company's oil pipelines.The Houston-based oil and gas company also argues that the issuance of a cease-and-desist is not in accordance with correct procedures given the context of the work, according to a Securities and Exchange Commission filing on Wednesday.Sable, citing Section 30809 of the Coastal Act, said that a cease-and-desist order can only be issued by the agency's executive director in specific instances. These include when the activity that has been undertaken \"may require a permit from the commission without securing a permit,\" or when the activity \"may be inconsistent with any permit previously issued by the commission,\" according to the filing.Sable additionally argued that the County of Santa Barbara earlier this month notified Sable ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","SOC"],"gpt_icon":0},{"id":"2512486216","title":"BRIEF-Sable Offshore Corp Files Complaint Against California Coastal Commission","url":"https://stock-news.laohu8.com/highlight/detail?id=2512486216","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512486216?lang=en_us&edition=fundamental","pubTime":"2025-02-19 23:33","pubTimestamp":1739979188,"startTime":"0","endTime":"0","summary":"BRIEF-Sable Offshore Corp Files Complaint Against California Coastal CommissionFeb 19  - Sable Offshore Corp SOC.N:SABLE OFFSHORE CORP - ON FEB 16, CALIFORNIA COASTAL COMMISSION  ISSUED NOTICE TO SABLE OFFSHORE FOR ANOMALY REPAIR WORKSABLE OFFSHORE CORP - REPLIES TO CCC, INTENDS TO PROCEED WITH REPAIR WORKSABLE OFFSHORE CORP - ON FEB 18, CO FILED A COMPLAINT AGAINST CCCSABLE OFFSHORE CORP - PIPELINE REPAIR OPERATIONS REMAIN UNAFFECTED BY CCC ORDERSource text: [ID:n0001831481-25-000006]Further company coverage: SOC.N ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nFWN3PA1BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4213","SOC"],"gpt_icon":0},{"id":"2512485018","title":"Sable Offshore Corp - on Feb 16, California Coastal Commission (Ccc) Issued Notice to Sable Offshore for Anomaly Repair Work","url":"https://stock-news.laohu8.com/highlight/detail?id=2512485018","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512485018?lang=en_us&edition=fundamental","pubTime":"2025-02-19 23:16","pubTimestamp":1739978200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250219:nFWN3PA1BL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4213","SOC"],"gpt_icon":0},{"id":"2512488452","title":"Sable Offshore Corp trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2512488452","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512488452?lang=en_us&edition=fundamental","pubTime":"2025-02-19 22:25","pubTimestamp":1739975126,"startTime":"0","endTime":"0","summary":"09:23 EST Sable Offshore (SOC) Corp trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving break...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sable-offshore-corp-trading-halted-news-pending?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sable-offshore-corp-trading-halted-news-pending?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4605","ON","BK4141","IE00BZ199S13.USD","LU1854103824.USD","LU0724618433.USD","LU0348723411.USD","LU1548497426.USD","LU2357305700.SGD","BK4585","LU2298322129.HKD","BK4512","BK4588","LU1720051017.SGD","BK4213","LU1861220033.SGD","LU1978683503.SGD","LU0124384867.USD","LU2360107325.USD","LU1854104046.USD","LU1720051108.HKD","IE00BD6J9T35.USD","LU1861219969.SGD","LU1861215975.USD","SOC","LU1861214812.USD"],"gpt_icon":0},{"id":"2512919772","title":"U.S. RESEARCH ROUNDUP-Boeing, Philip Morris, Walmart","url":"https://stock-news.laohu8.com/highlight/detail?id=2512919772","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512919772?lang=en_us&edition=fundamental","pubTime":"2025-02-17 16:11","pubTimestamp":1739779876,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Boeing, Philip Morris, WalmartFeb 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Boeing, Phili","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250217:nL3N3P80IU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417517546.SGD","PLMR","IE00BDGV0183.EUR","CME","LU0149725797.USD","WMT","LU0266013472.USD","CCL","PM","IE000M9KFDE8.USD","MRNA","LU2505996509.AUD","LU1066051498.USD","LU2355687059.USD","WST","CCL.UK","LU1153585028.USD","DKNG","ALB","CGNX","IDYA","RSG","LU0738911758.USD","IR","NOG","LU2361045086.USD","PAYC","R","LU2023251221.USD","LU2023250504.SGD","LU1732800096.USD","CW","BA","LU2750360641.GBP","LU0265550946.USD","BK4023","BK4561","GNRC","TWLO","LU1718418525.SGD","RCL","BK4232","BK5086","GB00B4QBRK32.GBP","ST","LU2592432038.USD","BK4568","MSA","HWM","SOC"],"gpt_icon":1},{"id":"2512199946","title":"Sable Offshore Corp : Jefferies Raises Target Price to $38 From $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2512199946","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512199946?lang=en_us&edition=fundamental","pubTime":"2025-02-17 12:42","pubTimestamp":1739767323,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250217:nFWN3P60G0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4213","SOC"],"gpt_icon":0}],"pageSize":16,"totalPage":10,"pageCount":2,"totalSize":153}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SOC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-17","symbol":"SOC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"SOC","fiscalQuarterEnding":"2024/09","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-1.24},{"market":"US","date":"2024-08-13","symbol":"SOC","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-2.75},{"date":"2024-05-15","symbol":"SOC","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1715803200000,"name":null,"time":"Post Market","dateTimestamp":1715745600000,"actualEps":null},{"market":"US","date":"2024-03-28","symbol":"SOC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1711598400000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SOC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SOC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.6,"hold":0,"sell":0.2,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1730779200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SOC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SOC","date":"2025-03-26","current":-3.743874,"percent":0.74031,"low":-49.514744,"twenty":-19.765904,"median":-4.489672,"eighty":-3.611722,"high":-2.365452,"avg":-10.998255,"sd":13.782072,"marketCap":2355147849},"quantilePoints":[{"date":"2024-02-16","current":-10.965511,"twenty":-10.965511,"median":-10.965511,"eighty":-10.965511,"marketCap":164955978},{"date":"2024-02-23","current":-47.994905,"twenty":-48.050899,"median":-47.994905,"eighty":-40.589026,"marketCap":721995228},{"date":"2024-03-01","current":-48.874812,"twenty":-48.810818,"median":-47.994905,"eighty":-47.810925,"marketCap":735231807},{"date":"2024-03-08","current":-48.51485,"twenty":-48.842815,"median":-48.51485,"eighty":-47.970908,"marketCap":729816842},{"date":"2024-03-15","current":-46.995011,"twenty":-48.834816,"median":-48.13489,"eighty":-47.810925,"marketCap":706953660},{"date":"2024-03-22","current":-44.715253,"twenty":-48.802819,"median":-47.994905,"eighty":-46.491065,"marketCap":672658887},{"date":"2024-03-28","current":-44.475279,"twenty":-48.79482,"median":-47.954909,"eighty":-44.667258,"marketCap":669048911},{"date":"2024-04-05","current":-20.510023,"twenty":-48.626838,"median":-47.554952,"eighty":-43.603371,"marketCap":660023970},{"date":"2024-04-12","current":-20.47263,"twenty":-48.442858,"median":-46.715041,"eighty":-20.502545,"marketCap":658820645},{"date":"2024-04-19","current":-19.182574,"twenty":-48.32287,"median":-44.795244,"eighty":-20.47263,"marketCap":617305919},{"date":"2024-04-26","current":-19.5752,"twenty":-48.106893,"median":-44.595266,"eighty":-20.42028,"marketCap":629940836},{"date":"2024-05-03","current":-19.593896,"twenty":-47.994905,"median":-43.535379,"eighty":-19.762164,"marketCap":630542499},{"date":"2024-05-10","current":-20.659595,"twenty":-47.994905,"median":-20.566113,"eighty":-19.777121,"marketCap":664837272},{"date":"2024-05-17","current":-26.212445,"twenty":-47.994905,"median":-20.911997,"eighty":-19.833211,"marketCap":843531091},{"date":"2024-05-24","current":-4.001469,"twenty":-47.970907,"median":-20.566113,"eighty":-19.605114,"marketCap":803821353},{"date":"2024-05-31","current":-4.492667,"twenty":-47.922913,"median":-20.510023,"eighty":-19.496675,"marketCap":902494035},{"date":"2024-06-07","current":-4.456726,"twenty":-47.746932,"median":-20.481978,"eighty":-19.242403,"marketCap":895274082},{"date":"2024-06-14","current":-4.444746,"twenty":-47.554952,"median":-20.47263,"eighty":-4.563951,"marketCap":892867431},{"date":"2024-06-21","current":-4.336922,"twenty":-47.554952,"median":-20.47263,"eighty":-4.498658,"marketCap":871207575},{"date":"2024-06-28","current":-4.375858,"twenty":-47.330976,"median":-20.453933,"eighty":-4.49087,"marketCap":879029190},{"date":"2024-07-05","current":-4.729281,"twenty":-46.939017,"median":-20.360451,"eighty":-4.493865,"marketCap":950025387},{"date":"2024-07-12","current":-4.666384,"twenty":-46.491065,"median":-20.080004,"eighty":-4.499856,"marketCap":937390471},{"date":"2024-07-15","current":-4.792179,"twenty":-46.267089,"median":-20.014567,"eighty":-4.501054,"marketCap":962660304},{"date":"2024-08-02","current":-4.753242,"twenty":-46.043112,"median":-19.949129,"eighty":-4.502252,"marketCap":954838689},{"date":"2024-08-09","current":-4.193156,"twenty":-45.163206,"median":-19.771513,"eighty":-4.476494,"marketCap":842327766},{"date":"2024-08-16","current":-2.818059,"twenty":-44.779246,"median":-19.612593,"eighty":-4.43576,"marketCap":969439268},{"date":"2024-08-23","current":-2.836909,"twenty":-44.643261,"median":-19.584548,"eighty":-4.379452,"marketCap":975923811},{"date":"2024-08-30","current":-3.106462,"twenty":-44.595266,"median":-19.425628,"eighty":-4.335724,"marketCap":1068652785},{"date":"2024-09-06","current":-4.073462,"twenty":-44.547271,"median":-19.332146,"eighty":-4.230058,"marketCap":1401309871},{"date":"2024-09-13","current":-3.988638,"twenty":-44.235304,"median":-7.878845,"eighty":-4.193156,"marketCap":1372129425},{"date":"2024-09-20","current":-5.33452,"twenty":-43.603371,"median":-4.857618,"eighty":-4.199566,"marketCap":1835125838},{"date":"2024-09-27","current":-5.343032,"twenty":-36.402227,"median":-4.781696,"eighty":-4.199566,"marketCap":1838054195},{"date":"2024-10-04","current":-5.755604,"twenty":-24.956043,"median":-4.880237,"eighty":-4.209959,"marketCap":1979982860},{"date":"2024-10-11","current":-4.598218,"twenty":-22.592809,"median":-4.868927,"eighty":-4.213365,"marketCap":1581830780},{"date":"2024-10-18","current":-4.725113,"twenty":-21.590679,"median":-4.792179,"eighty":-4.229539,"marketCap":1625484098},{"date":"2024-10-25","current":-4.888949,"twenty":-20.962478,"median":-4.790222,"eighty":-4.249285,"marketCap":1681845104},{"date":"2024-10-31","current":-4.998173,"twenty":-20.648377,"median":-4.810961,"eighty":-4.266836,"marketCap":1719419108},{"date":"2024-11-08","current":-5.61315,"twenty":-20.596027,"median":-4.880237,"eighty":-4.334526,"marketCap":1930977089},{"date":"2024-11-15","current":-3.401519,"twenty":-20.554895,"median":-4.900821,"eighty":-4.334526,"marketCap":2003855918},{"date":"2024-11-22","current":-3.557753,"twenty":-20.510023,"median":-4.857618,"eighty":-4.212246,"marketCap":2051078846},{"date":"2024-11-29","current":-3.628847,"twenty":-20.510023,"median":-4.805844,"eighty":-4.193156,"marketCap":2092064783},{"date":"2024-12-06","current":-2.944188,"twenty":-20.491327,"median":-4.779739,"eighty":-4.113047,"marketCap":1697352390},{"date":"2024-12-13","current":-3.083283,"twenty":-20.491327,"median":-4.753242,"eighty":-3.988638,"marketCap":1777542266},{"date":"2024-12-20","current":-3.440295,"twenty":-20.47263,"median":-4.727197,"eighty":-3.815772,"marketCap":1983362950},{"date":"2024-12-27","current":-3.676757,"twenty":-20.47263,"median":-4.697136,"eighty":-3.712613,"marketCap":2119685740},{"date":"2025-01-03","current":-3.597937,"twenty":-20.47263,"median":-4.668442,"eighty":-3.657593,"marketCap":2074244810},{"date":"2025-01-10","current":-3.51757,"twenty":-20.47263,"median":-4.649598,"eighty":-3.630083,"marketCap":2027912881},{"date":"2025-01-17","current":-3.811216,"twenty":-20.47263,"median":-4.615467,"eighty":-3.610301,"marketCap":2197202621},{"date":"2025-01-24","current":-4.367598,"twenty":-20.465151,"median":-4.609477,"eighty":-3.628847,"marketCap":2517962128},{"date":"2025-01-31","current":-3.859127,"twenty":-20.427758,"median":-4.5959,"eighty":-3.629465,"marketCap":2224823579},{"date":"2025-02-07","current":-3.491297,"twenty":-20.382887,"median":-4.55257,"eighty":-3.628847,"marketCap":2012765905},{"date":"2025-02-14","current":-4.733883,"twenty":-20.293145,"median":-4.531604,"eighty":-3.604119,"marketCap":2729128803},{"date":"2025-02-21","current":-4.54224,"twenty":-20.173487,"median":-4.551073,"eighty":-3.628847,"marketCap":2618644973},{"date":"2025-02-28","current":-4.291868,"twenty":-20.080004,"median":-4.534513,"eighty":-3.628847,"marketCap":2474303195},{"date":"2025-03-07","current":-3.568572,"twenty":-19.949129,"median":-4.506443,"eighty":-3.628847,"marketCap":2057315836},{"date":"2025-03-14","current":-3.656666,"twenty":-19.855647,"median":-4.498658,"eighty":-3.616483,"marketCap":2108102758},{"date":"2025-03-21","current":-3.688441,"twenty":-19.799557,"median":-4.493498,"eighty":-3.616483,"marketCap":2320276640},{"date":"2025-03-26","current":-3.743874,"twenty":-19.765904,"median":-4.489672,"eighty":-3.611722,"marketCap":2355147849}],"updateTime":1743099863940}}}